Danaher to Present at J.P. Morgan Healthcare Conference
Rhea-AI Summary
Danaher (NYSE: DHR) said its President and Chief Executive Officer, Rainer M. Blair, will present at the J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026 at 11:15 a.m. PT.
The presentation will be simultaneously webcast and accessible from the company's Investors site under Events & Presentations at www.danaher.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DHR gained 0.52%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves: TMO +2.25%, A +1.23%, MTD +0.90%, LH +0.14%, while IDXX declined -0.97%, suggesting stock-specific factors rather than a uniform sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 17 | Earnings call schedule | Neutral | -0.9% | Set date and access details for upcoming Q4 2025 earnings call. |
| Dec 09 | Dividend declaration | Positive | +3.2% | Announced regular quarterly cash dividend of $0.32 per share. |
| Nov 11 | Conference presentation | Positive | +1.7% | CEO scheduled to present at Jefferies Global Healthcare Conference. |
| Oct 21 | Earnings results | Positive | +5.9% | Q3 2025 results with revenue growth and maintained EPS guidance. |
| Sep 23 | Earnings call schedule | Neutral | -2.0% | Announced timing and access details for Q3 2025 earnings call. |
Recent price reactions tended to be positive on earnings results and conference participation, while simple earnings-call scheduling updates had modest negative moves.
Over the last few months, Danaher highlighted several investor-focused events and results. A Q3 2025 earnings report on Oct 21, 2025 showed revenue of $6.1B and lifted shares by 5.94%. A regular dividend of $0.32 per share announced on Dec 9, 2025 coincided with a 3.22% gain. Conference-related announcements, including a Jefferies healthcare presentation, drew smaller but positive moves, while scheduling earnings calls saw mild declines. Today’s J.P. Morgan conference notice fits this pattern of communication aimed at investors and analysts via the company’s website.
Market Pulse Summary
This announcement sets expectations for Danaher’s presence at the J.P. Morgan Healthcare Conference on January 13, 2026, offering another venue for management to communicate strategy and outlook. It follows recent earnings, dividend, and conference updates that kept investors informed via webcasts and the company’s site. Investors may watch for any commentary that builds on prior Q3 2025 results, dividend policies, and sector trends discussed in earlier events.
Key Terms
nyse financial
AI-generated analysis. Not financial advice.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-jp-morgan-healthcare-conference-302652819.html
SOURCE Danaher Corporation